Complementary and Alternative Medicine for Painful Peripheral Neuropathy
Purpose of review
The purpose of our manuscript is to review the current evidence supporting the use of complementary and alternative medicine (CAM) in neuromuscular disease, specifically in painful peripheral neuropathy (PPN). We outline the therapeutic challenges of this debilitating condition and describe the best evidence for incorporating such therapies into clinical practice. The most studied modalities include lifestyle modifications with diet and exercise, supplements, and acupuncture. CAM therapies such as yoga, meditation, electrical stimulation, neuromodulatory devices, and cannabis are mentioned as emerging therapies.
Current data suggests that targeted lifestyle modifications, including aerobic exercise and diet modifications that promote weight loss, may improve the natural course of diabetic painful neuropathy and potentially other types of neuropathy. A number of studied dietary supplements and vitamins including B vitamins, vitamin D, alpha-lipoic acid, and acetyl-l-carnitine improve both subjective and objective neuropathic measures. A wide range of neuromodulatory devices and electrical stimulation modalities demonstrate mixed results, and further studies are needed to confirm their benefit. Finally, acupuncture and yoga both demonstrate benefit in a variety of PPNs.
Multiple CAM therapies show efficacy in the treatment of PPN. From the strongest level of evidence to the least, lifestyle modifications including exercise and diet; supplements including B12, alpha lipoic acid, acetyl-l-carnitine, and vitamin D in deficient patients; followed by acupuncture and yoga may alleviate symptoms of PPN.
KeywordsDiabetic neuropathy Alternative therapies Neuropathy treatment Peripheral neuropathy Neuromodulation
The authors would like to thank Ms. Indra Maria Newman for her editing support.
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 1.Rutkove S, Shefner JM, Eichler AF. Overview of polyneuropathy. UpToDate. 2018.Google Scholar
- 4.Feldman EL, Shefner JM, Dashe JF. Epidemiology and classification of diabetic neuropathy. UpToDate. 2013. https://doi.org/10.1017/CBO9781107415324.004.
- 9.Tavakoli M, Asghar O, Alam U, Petropoulos IN, Fadavi H, Malik RA. Novel insights on diagnosis, cause and treatment of diabetic neuropathy: focus on painful diabetic neuropathy. Ther Adv Endocrinol Metab. 2010;1(2):69–88. https://doi.org/10.1177/2042018810370954.CrossRefPubMedPubMedCentralGoogle Scholar
- 10.•• Cruccu G, Truini A. A review of neuropathic pain: from guidelines to clinical practice. Pain Ther. 2017;6(S1):35–42. https://doi.org/10.1007/s40122-017-0087-0. This paper provides a comprehensive groundwork for the difficulties and history of treatment of neuropathic pain in clinical practice.CrossRefPubMedPubMedCentralGoogle Scholar
- 13.Colloca L, Ludman T, Bouhassira D, et al. HHS Public Access. 2017;(Imi). https://doi.org/10.1038/nrdp.2017.2.Neuropathic.
- 17.•• Dixit D, Maiya A, Shastry BA. Effects of aerobic exercise of vibration perception threshold in type 2 diabetic peripheral neuropathy using 3-sites method: single-blind randomized controlled trial. Altern Ther Health Med. 2019;25(2):36–41 This randomized trial outlines the effect of incorporating exercise into the treatment regimen of diabetics with neuropathic pain on their sensory exam.PubMedPubMedCentralGoogle Scholar
- 22.•• Look AHEAD Research Group. Effects of a long-term lifestyle modification programme on peripheral neuropathy in overweight or obese adults with type 2 diabetes: the Look AHEAD study. Diabetologia. 2017;60(6):980–8. https://doi.org/10.1007/s00125-017-4253-z. This trial highlights the importance of lifestyle modifications including weight loss on the impact of neuropathic pain symptoms.CrossRefGoogle Scholar
- 23.Tin SNW, Zouari HG, Ayache SS, et al. Coaching of lifestyle recommendations improves sensory neurophysiological parameters in neuropathies related to glycemic disorder or metabolic syndrome. A pilot study. Neurophysiol Clin. 2019;49(1):59–67. https://doi.org/10.1016/j.neucli.2018.12.004.CrossRefGoogle Scholar
- 26.•Sil A, Kumar H, Mondal RD, Anand SS, Ghosal A, Datta A, et al. A randomized, open labeled study comparing the serum levels of cobalamin after three doses of 500mcg vs a single dose methylcobalamin of 1500 mcgin patients with peripheral neuropathy. Korean J Pain. 2018;31(3):183–90. https://doi.org/10.3344/kjp.2018.31.3.183. This paper compares the cellular uptake of Methylcobalamin (MC) and cobalamin in patients with peripheral neuropathy.PubMedPubMedCentralCrossRefGoogle Scholar
- 29.Jiang DQ, Li MX, Wang Y, Wang Y. Effects of prostaglandin E1 plus methylcobalamin alone and in combination with lipoic acid on nerve conduction velocity in patients with diabetic peripheral neuropathy: a meta-analysis. Neurosci Lett. 2015;594:23–9. https://doi.org/10.1016/j.neulet.2015.03.037.CrossRefPubMedGoogle Scholar
- 31.•Mottaghi T, Khorvash F, Maracy M, Bellissimo N, Askari G. Effect of folic acid supplementation on nerve conduction velocity in diabetic polyneuropathy patients. Neurol Res. 2019;41(4):364–8. https://doi.org/10.1080/01616412.2019.1565180. Results from this study show that folic acid supplementation for 16 weeks may be enhance nerve conduction velocity in patients with diabetic polyneuropathy.PubMedCrossRefPubMedCentralGoogle Scholar
- 37.•Chu C, Zhao W, Zhang Y, Li L, Lu J, Jiang L, et al. Low serum magnesium levels are associated with impaired peripheral nerve function in type 2 diabetic patients. Sci Rep. 2016:32623. https://doi.org/10.1038/srep32623. The study (n=978) explores the relationship between serum magnesium and peripheral nerve function in patients with type 2 diabetes, suggesting a correlation between magnesium levels and peripheral nerve function via axonal degeneration.
- 38.•Zhang Q, Ji L, Zheng H, Li Q, Ziong Q, Sun W, et al. Low serum phosphate and magnesium levels are associated with peripheral neuropathy in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2018;146:1–7. https://doi.org/10.1016/j.diabres.2018.09.015. This study in patients with type 2 diabetes demonstrates a significant correlational relationship between lower serum phosphate and magnesium levels with various parameters of nerve conduction, suggesting the pathophysiological importance of serum phosphate and magnesium in DPN.PubMedCrossRefPubMedCentralGoogle Scholar
- 40.Reljanovic M, Reichel G, Rett K, Lobisch M, Schuette K, Möller W, et al. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha lipoic acid in diabetic neuropathy. Free Radic Res. 1999;31(3):171–9.Google Scholar
- 41.••Agathos E, Tentolouris A, Eleftheriadou I, Katsaouni P, Nemtzas I, Petrou A, et al. Effect of a-lipoic acid on symptoms and quality of life in patients with painful diabetic neuropathy. J Int Med Res. 2018;46(5):1779–90. https://doi.org/10.1177/0300060518756540. This study investigates dose and clinical use of ALA in neuropathic pain.PubMedCrossRefPubMedCentralGoogle Scholar
- 47.••Li S, Chen X, Li Q, Du J, Liu Z, Peng Y, et al. Effects of acetyl-L-carnitine and methylcobalamin for diabetic peripheral neuropathy: a multicenter, randomized, double-blind, controlled trial. J Diabetes Investig. 2016;7(5):777–85. A well-designed randomized trial comparing acetyl-L-carnitine with methylcobalamin and found benefit (noninferiority) with ALC.PubMedPubMedCentralCrossRefGoogle Scholar
- 51.Verhulst AL, Savelberg HH, Vreugdenhil G, Mischi M, Schep G. Whole-body vibration as a modality for the rehabilitation of peripheral neuropathies: implications for cancer survivors suffering from chemotherapy-induced peripheral neuropathy. Oncol Rev. 2015;9(1):263.PubMedPubMedCentralCrossRefGoogle Scholar
- 53.Kordi Yoosefinejad A, Shadmehr A, Olyaei G, Talebian S, Bagheri H, Mohajeri-Tehrani MR. Short-term effects of the whole-body vibration on the balance and muscle strength of type 2 diabetic patients with peripheral neuropathy: a quasi-randomized-controlled trial study. J Diabetes Metab Disord. 2015;14:4. eCollection 2015.Google Scholar
- 55.•Smith TJ, Razzak AR, Blackford AL, Ensminger J, Saiki C, Longo-Schoberlein D, et al. A pilot randomized sham-controlled trial of MC5-a scrambler therapy in the treatment of chronic chemotherapy-induced peripheral neuropathy. J Palliat Care. 2019:825859719827589. https://doi.org/10.1177/0825859719827589. This study is a randomized sham-controlled Phase II trial of scrambler therapy in chemotherapy-induced peripheral neuropathy, demonstrating no difference between sham and real scrambler therapy.
- 56.Pachman DR, Weisbrod BL, Seisler DK, Barton DL, Fee-Schroeder KC, Smith TJ, et al. Pilot evaluation of scrambler therapy for the treatment of chemotherapy induced peripheral neuropathy. Support Care Cancer. 2015;23(4):943–51. https://doi.org/10.1007/s00520-014-2424-8.PubMedPubMedCentralCrossRefGoogle Scholar
- 58.Hegde SV, Adhikari P, Shetty S, Manjrekar P, D’Souza V. Effect of community-based yoga intervention on oxidative stress and glycemic parameters in prediabetes: a randomized controlled trial. Complement Ther Med. 2013;21(6):571–6. https://doi.org/10.1016/j.ctim.2013.08.013.CrossRefPubMedGoogle Scholar
- 61.•Van Puymbroeck M, Atler K, Portz JD, Schmid AA. multidimensional improvements in health following hatha yoga for individuals with diabetic peripheral neuropathy. Int J Yoga Therap. 2018;28(1):71–8. https://doi.org/10.17761/2018-00027. In patients with diabetic peripheral neuropathy completing an 8-week Hatha Yoga trial, it has been suggested that yoga can improve neuromuscular and movement-based functions, sensory functions, and stress management and sleep improvement via breathwork. In addition, participation, social support, and environmental factors may contribute to a holistic improvement of health.PubMedCrossRefGoogle Scholar
- 65.•Lim TK, Ma Y, Berger F, Litscher G. Acupuncture and neural mechanism in the management of low back pain-an update. Medicines (Basel). 2018;5(3):63. Published 2018. https://doi.org/10.3390/medicines5030063. This review focuses on the analgesic effects of acupuncture on low back pain as well as the neurological mechanisms and incidence of low back pain globally.PubMedCentralCrossRefPubMedGoogle Scholar
- 67.•• Dimitrova A, Murchison C, Oken B. Acupuncture for the treatment of peripheral neuropathy: a systematic review and meta-analysis. J Altern Complement Med. 2017;23(3):164–79. https://doi.org/10.1089/acm.2016.0155 A succinct review of potential mechanisms and beneficial use of acupuncture in neuropathic pain.CrossRefPubMedPubMedCentralGoogle Scholar
- 68.•Shin KM, Lee S, Lee EY, Kim CH, Kang JW, Lee CK, et al. Electroacupuncture for painful diabetic peripheral neuropathy: a multicenter, randomized, assessor-blinded, controlled trial. Diabetes Care. 2018;41(10):e141–2. https://doi.org/10.2337/dc18-1254. The study explores the effectiveness and safety of electroacupuncture in the treatment of painful diabetic neuropathy (PDN) compared to placebo and usual care.
- 69.•Zhi WI, Ingram E, Li SQ, Chen P, Piulson L, Bao T. Acupuncture for bortezomib-induced peripheral neuropathy: not just for pain. Integr Cancer Ther. 2018;17(4):1079–86. https://doi.org/10.1177/1534735418788667. This study examines the safety and efficacy of acupuncture in Bortezomib-induced peripheral neuropathy (BIPN), demonstrating that acupuncture can decrease total neuropathic symptoms, especially cold sensitivity and numbness and tingling in hands and feet.PubMedPubMedCentralCrossRefGoogle Scholar
- 70.•Bao T, Seidman AD, Piulson L, Vertosick E, Chen X, Vickers AJ, et al. A phase IIA trial of acupuncture to reduce chemotherapy-induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer patients. Eur J Cancer. 2018;101:12–9. https://doi.org/10.1016/j.ejca.2018.06.008. This study in chemotherapy-induced peripheral neuropathy showed acupuncture to be was safe and effective in reducing the incidence of high grade CIPN during chemotherapy.PubMedPubMedCentralCrossRefGoogle Scholar
- 71.Hashempur MH, Homayouni K, Ashraf A, Salehi A, Taghizadeh M, Heydari M. Effect of Linum usitatissimum L. (linseed) oil on mild and moderate carpal tunnel syndrome: a randomized, double-blind, placebo-controlled clinical trial. Daru. 2014;22:43. https://doi.org/10.1186/2008-2231-22-43.CrossRefPubMedPubMedCentralGoogle Scholar
- 72.•Hashempur MH, Ghasemi MS, Daneshfard B, Fhoreishi PS, Lari ZN, Homayouni K, et al. Efficacy of topical chamomile oil for mild and moderate carpal tunnel syndrome: a randomized double-blind placebo-controlled clinical trial. Complement Ther Clin Pract. 2017;26:61–7. https://doi.org/10.1016/j.ctcp.2016.11.010. This study evaluates the efficacy of topical chamomile oil as a complementary treatment in patients with mild and moderate carpal tunnel syndrome (CTS) as measured through functional and symptomatic scores, dynamometry, and electrodiagnostic indexes.PubMedCrossRefPubMedCentralGoogle Scholar
- 73.Bellampalli SS, Ji Y, Moutal A, Cai S, Wijeratne EMK, Gandini MA, et al. Betulinic acid, derived from the desert lavender Hyptis emoryi, attenuates paclitaxel-, HIV-, and nerve injury-associated peripheral sensory neuropathy via block of N- and T-type calcium channels. Pain. 2019;160(1):117–35. https://doi.org/10.1097/j.pain.0000000000001385.PubMedCrossRefPubMedCentralGoogle Scholar
- 74.•Castelli V, Palumbo P, d’Angelo M, Moorthy NK, Antonosante A, Catanesi M, et al. Probiotic DSF counteracts chemotherapy induced neuropathic pain. Oncotarget. 2018;9(46):27998–8008. https://doi.org/10.18632/oncotarget.25524. This study test the effects of probiotics on counteracting paclitaxel-induced neuropathic pain since probiotics are capable of regulating the anti-inflammatory and pro-inflammatory cytokines. The study resulted in an increase in acetylated tubulin.
- 75•.Youn Y, Hellman A, Walling I, Gee L, Qian J, Burdette C, et al. High-intensity ultrasound treatment for vincristine-induced neuropathic pain. Neurosurgery. 2018;83(5):1068–75. https://doi.org/10.1093/neuros/nyx488. This study determining the effects of pulsed high-intensity focused ultrasound (HIFU) on sensory thresholds in a vincristine-induced neuropathy (VIN) rodent model, resulting in increases mechanical and thermal thresholds.PubMedCrossRefPubMedCentralGoogle Scholar
- 76.•Prinsloo S, Novy D, Driver L, Lyle R, Ramondetta L, Eng C, et al. The long-term impact of neurofeedback on symptom burden and interference in patients with chronic chemotherapy-induced neuropathy: analysis of a randomized controlled trial. J Pain Symptom Manag. 2018;55(5):1276–85. https://doi.org/10.1016/j.jpainsymman.2018.01.010. This study on the long-term effects of electroencephalographic neurofeedback (NFB) as a treatment for chemotherapy-induced peripheral neuropathy (CIPN) in 71 cancer survivors demonstrates that NFB results in CIPN symptom reductions and improved quality of life and fatigue.PubMedCrossRefPubMedCentralGoogle Scholar